Avantor Investor Conference Presentation Deck

M&A as enhancement to mid-term EPS growth RIGOROUS FRAMEWORK Areas of interest: Biopharma production R&D workflows Services Geographic expansion Value metrics: Accretive to organic growth, EBITDA margin Minimum high-single-digit ROIC Rapid leverage recovery avantor™ 1. 2011-2020 including legacy VWR transactions 2. From VWR integration 40 Deals closed¹ STRONG TRACK RECORD >$8B Capital deployed¹ $350M+ Synergies attained² GROWING CAPACITY & CAPABILITY >$1B capacity excluding share issuance M&A organization in place, pipeline growing 39th Annual J.P. Morgan Healthcare Conference 17

View entire presentation